AIMC Topic: Tigecycline

Clear Filters Showing 1 to 2 of 2 articles

Construction and temporal external validation of interpretable machine-learning models for predicting tigecycline-associated hypofibrinogenemia.

European journal of clinical pharmacology Jan 3, 2026
BACKGROUND AND PURPOSE: There is a paucity of available clinical tools with which to accurately predict the risk of tigecycline-associated hypofibrinogenemia, an adverse reaction with a high incidence and serious consequences. This study aimed to dev...
Humans Machine Learning Algorithms Anti-Bacterial Agents Female Aged Aged, 80 and over Adult Male Middle Aged Fibrinogen Tigecycline Fibrin Fibrinogen Degradation Products Partial Thromboplastin Time Afibrinogenemia
View on PubMed DOI

Molecular mechanisms of antibiotic co-resistance among carbapenem resistant Acinetobacter baumannii.

Journal of infection in developing countries Oct 31, 2019
INTRODUCTION: The spread of carbapenem-resistant Acinetobacter baumannii (CRAB) is difficult to control especially in the hospitals due to the successful mobilization and evolution of the genetic elements harboring the resistant determinants. The stu...
Humans Anti-Bacterial Agents Female Male Microbial Sensitivity Tests Bacterial Proteins Tertiary Care Centers Drug Resistance, Microbial beta-Lactamases Pakistan Acinetobacter Infections Acinetobacter baumannii Carbapenems Colistin Tigecycline
View on PubMed DOI
Popular Topics
Recent Journals